Research advances in molecular targeted therapy for advanced biliary tract cancer

Research advances in molecular targeted therapy for advanced biliary tract cancer

Molecular targeted therapy has become a new hot spot with the in-depth basic research on advanced biliary tract cancer (ABTC). Phase Ⅱ and Ⅲ trials of the molecular targeted therapies for ABTC are summarized to provide new insights into clinical practice. Phase II trials have shown that vascular end...

Full description

Bibliographic Details
Main Author:	LI Mingwu
Format:	Article
Language:	zho
Published:	Editorial Department of Journal of Clinical Hepatology 2014-11-01
Series:	Linchuang Gandanbing Zazhi
Subjects:	biliary tract neoplasms; targeted therapy; receptor epidermal growth factor; vascular endothelial growth factors; mitogen-activated protein kinases; review
Online Access:	http://www.lcgdbzz.org/qk_content.asp?id=6132&ClassID=101793132

Similar Items

Targeting Angiogenesis in Biliary Tract Cancers: An Open Option
by: Valeria Simone, et al.
Published: (2017-02-01)

Recent advances of novel targeted therapy for squamous cell carcinoma of the head and neck
by: Jed A. Katzel, et al.
Published: (2011-12-01)

Novel targeted agents for the treatment of bladder cancer: translating laboratory advances into clinical application
by: Xiaoping Yang, et al.
Published: (2010-06-01)

Targeted and novel therapy in advanced gastric cancer
by: Julie H. Selim, et al.
Published: (2019-10-01)

Ophthalmic complications of targeted therapies: a review
by: Deepti Sharma
Published: (2017-01-01)

Clinical Observation of EGFR-TKI as A First-line Therapy on Advanced Non-small Cell Lung Cancer
by: Jianjie LI, et al.
Published: (2012-05-01)

Expressions and Their Significances of Vascular Endothelial Growth Factor-C mRNA and Epidermal Growth Factor Receptor mRNA in Non-small Cell Lung Cancer Tissues and Lymph Node Tissues
by: Yan GUAN, et al.
Published: (2010-12-01)

Effects of EGFT-TKIs on Sequential Pemetrexed  for Advanced Pulmonary Adenocarcinoma
by: Xiangying WANG, et al.
Published: (2012-05-01)

Improving Outcomes in Advanced Lung Cancer : Maintenance therapy in non-small-cell lung carcinoma
by: Muhammad Furrukh, et al.
Published: (2013-02-01)

Clinical Predictive Factors associated with First Line EGFR-TKI Efficacy  in Advanced NSCLC Patients with EGFR Mutations
by: Minjiang CHEN, et al.
Published: (2019-02-01)

Advances in Antiangiogenic Treatment of Advanced Non-squamous Non-small Cell Lung Cancer in 2017 ASCO and WCLC
by: Lianfang NI, et al.
Published: (2018-05-01)

Prognostic Analysis of Patients with Advanced Non-small Cell Lung Cancer  in Different Genotypes
by: Ping LIU, et al.
Published: (2017-11-01)

Clinical Study of Erlotinib in the Treatment of Patients with Advanced Stage Non-small Cell Lung Cancer
by: Renhua GUO, et al.
Published: (2009-12-01)

Advances in diagnosis and treatment of malignant pleural mesothelioma
by: Giorgio Vittorio Scagliotti, et al.
Published: (2011-12-01)

Advances in diagnosis and treatment of malignant pleural mesothelioma
by: Giorgio Vittorio Scagliotti, et al.
Published: (2011-12-01)

Advances in Double Mutations of EGFR and ALK Gene in Non-small Cell Lung Cancer
by: Xin WANG, et al.
Published: (2018-09-01)

Recent Advances in Association of Estrogen and Non-small Cell Lung Cancer
by: Xiaosheng DING, et al.
Published: (2017-06-01)

Significance of HER2 expression in patients with upper tract urothelial carcinoma: A meta-analysis
by: Chia-Horng Chen, et al.
Published: (2016-12-01)

Detection and Evaluation of EGFR Mutation Status in Serum of Patients with Advanced Non-small Cell Lung Cancer Treated with EGFR-TKIs
by: Ling MA, et al.
Published: (2013-06-01)

Research Progress of Targeted Therapy for EGFR Gene in Non-small Cell Lung Cancer
by: Hui ZHANG, et al.
Published: (2017-01-01)

Targeted Therapies in Advanced Biliary Tract Cancer: An Evolving Paradigm
by: Sakti Chakrabarti, et al.
Published: (2020-07-01)

Adverse Events of Afatinib as First-line Treatment for Five Cases of Advanced Lung Adenocarcinoma and Review of Literature
by: Hong TAO, et al.
Published: (2014-04-01)

Research Progress of Targeted Therapy for HER2 Gene  in Advanced Non-small Cell Lung Cancer
by: Lingping KONG, et al.
Published: (2020-12-01)

The Relationship between EGFR Mutations and Response and Prognosis of Tyrosine Kinase Inhibitors in Advanced Non-small-cell Lung Cancer
by: Xuebing LI, et al.
Published: (2008-04-01)

Application of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor as the First-line Therapy in Patients with Advanced Non-small Cell Lung Cancer
by: Chunsun LI, et al.
Published: (2010-01-01)

Targeted Therapy for Biliary Tract Cancer
by: Takuji Okusaka, et al.
Published: (2011-05-01)

EGFR Gene Mutation Statuses in Advanced Non-small Cell Lung Cancer Patients and Their Influence on Effect of Gefitinib
by: Wei ZHONG, et al.
Published: (2012-09-01)

Analysis of Treatment Response and Chest CT Characteristics for Patients Treated by EGFR-TKI in Relapse Advanced Lung Adenocarcinoma
by: Shuchang CHEN, et al.
Published: (2008-04-01)

Tyrosine kinase inhibitors for EGFR- and ALK-mutated non-small cell lung cancer
by: Jonathan R. Thompson, et al.
Published: (2016-10-01)

Efficacy of Chemotherapy after EGFR-TKIs Resistance in 191 Patients with Unknow EGFR Gene Mutation in Advanced Lung Adenocarcinoma
by: Ping HE, et al.
Published: (2013-10-01)

Advances in the Research of Autophagy in EGFR-TKI Treatment and Resistance  in Lung Cancer
by: Qicheng ZHANG, et al.
Published: (2016-09-01)

Potential Role of EGF and EGFR in Tongue Coating Formation
by: Yi-Shuang Tang, et al.
Published: (2016-12-01)

Treatment Progress for EGFR Wild-type Advanced Non-small Cell Lung Cancer
by: Feng MA, et al.
Published: (2014-07-01)

Clinical Advances in the Diagnosis and Treatment of Biliary Tract Diseases
Published: (2023)

Current management and future directions in the treatment of advanced renal cell carcinoma-a latin american perspective: 10 years in review
by: Oren Smaletz
Published: (2015-10-01)

How to Make the Choice in the Retreatment of EGFR-TKI for Advanced NSCLC Patients Who Benefited from Prior Gefitinib Therapy: the Original Drug or Switching to A Second EGFR-TKI?
by: Chuanhao TANG, et al.
Published: (2013-07-01)

Advanced Research on Non-small Cell Lung Cancer with De Novo T790M Mutation
by: Xin WANG, et al.
Published: (2019-05-01)

Role of FGF System in Neuroendocrine Neoplasms: Potential Therapeutic Applications
by: Giovanni Vitale, et al.
Published: (2021-04-01)

VEGFR-1 Regulates EGF-R to Promote Proliferation in Colon Cancer Cells
by: Hikaru Nagano, et al.
Published: (2019-11-01)

EGF Positively Regulates the Proliferation and Migration, and Negatively Regulates the Myofibroblast Differentiation of Periodontal Ligament-Derived Endothelial Progenitor Cells through MEK/ERK- and JNK-Dependent Signals
by: Hitomichi Kimura, et al.
Published: (2013-09-01)